Cosmetic physicians – and their patients — have a new, relatively inexpensive skin treatment in their arsenals as Led Technologies announced their latest product, the dpl Nüve. The handheld product is the second of the company’s deep penetrating light (DPL) devices and has received FDA approval. It is designed to treat pain, wrinkles and acne.
The device uses photons to penetrate into damaged tissue, increasing circulation to combat issues such as muscle spasms, minor muscle and joint aches and pains, and arthritis-related pain and stiffness. The device is non-invasive and has no side effects, according to the company.
In the company-led clinical studies, 13 subjects were given treatments during a 10-week period. All subjects reported visible improvements to skin, reducing fine lines and wrinkles while improving skin tone. Of those studied, 66 percent rated the procedure between a three and five on a scale of five when reducing periorbital wrinkles (crow’s feet).
According to the company Web site, the dpl Nüve will reduce the need for skin creams, spa treatments, pain remedies and possibly Botox. The device, which plugs into a wall outlet, uses 56 880 nanometer infrared and four 660 red light emitting diodes (LEDs). The device retails for $180, although the company is offering it for $160 for a limited time.
“The majority of the population has never been even introduced to light therapy, and we are expecting that to dramatically change in 2011,” said Brent Safer, Led Technologies LLC director of operations, following the FDA approval of the dpl Nüve in September 2010.